Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shunta Mori"'
Autor:
Naoyuki Nogami, Shunta Mori, Yumi Asakura, Daijiro Harada, Kenji Takata, Takayuki Ohno, Satoko Moriki, Toshiyuki Kozuki, Yoshika Takechi
Publikováno v:
Anticancer Research. 39:4987-4993
Background/aim For immune checkpoint inhibitor (ICI)-pretreated patients, docetaxel and ramucirumab (DOC+RAM) combination therapy may be more effective compared to patients not receiving ICI treatment. Patients and methods From June 2013 to July 2018
Autor:
Hiroki, Izumi, Shingo, Matsumoto, Jie, Liu, Kosuke, Tanaka, Shunta, Mori, Kumiko, Hayashi, Shogo, Kumagai, Yuji, Shibata, Takuma, Hayashida, Kana, Watanabe, Tatsuro, Fukuhara, Takaya, Ikeda, Kiyotaka, Yoh, Terufumi, Kato, Kazumi, Nishino, Atsushi, Nakamura, Ichiro, Nakachi, Shoichi, Kuyama, Naoki, Furuya, Jun, Sakakibara-Konishi, Isamu, Okamoto, Kageaki, Taima, Noriyuki, Ebi, Haruko, Daga, Akira, Yamasaki, Masahiro, Kodani, Hibiki, Udagawa, Keisuke, Kirita, Yoshitaka, Zenke, Kaname, Nosaki, Eri, Sugiyama, Tetsuya, Sakai, Tokiko, Nakai, Genichiro, Ishii, Seiji, Niho, Atsushi, Ohtsu, Susumu S, Kobayashi, Koichi, Goto
Publikováno v:
Cancer Cell
Identification of targetable fusions as oncogenic drivers in non-small cell lung cancer has transformed its diagnostic and therapeutic paradigm. In a recent article in Nature, Izumi et al. report the discovery of CLIP1-LTK fusion as a novel oncogenic